Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Mid-range Performer
1152.9000
0.90
(
0.08
%)
NSE
Jul 16, 2025
15:31 PM
27.58% Fall from 52W High
Volume:
580.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
28 May 2025
1152.90
0.08%
Result Update:Aurobindo Pharma
Buy:
Aurobindo Pharma Ltd.
by
Axis Direct
Target: 1500 | Upside : 30.1%
Axis Direct
We maintain our BUY recommendation on Aurobindo Pharma with a TP of Rs 1,500/share.
Aurobindo Pharma Ltd. is trading
below its 50 day SMA
of 1156.2
More from Aurobindo Pharma Ltd.
Recommended
Market closes flat, ITC Hotels' Q1FY26 net profit beats Forecaster estimates by 35.5%
Trendlyne Marketwatch |
16 Jul 2025, 03:59PM
Five stocks to buy from analysts this week - July 15, 2025
The Baseline |
15 Jul 2025, 06:44PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020, 03:06PM